The incidence and prevalence of pulmonary disease due to Non-tuberculous mycobacteria (NTM) is increasing worldwide, and this trend has been confirmed in Korea. Treatment of NTM pulmonary disease is difficult and usually requires more than two years of long-term treatment, and the antibiotic regimens used in treatment vary. Therefore, it is difficult to track the natural history of patients with NTM pulmonary disease, to evaluate the treatment outcome, and to understand the effect of specific medicines on the outcome. Establishing a prospective registry of patients with NTM pulmonary disease is expected to accurately evaluate the progress, treatment modality, and treatment outcome of NTM pulmonary disease.
Study Type
OBSERVATIONAL
Enrollment
1,000
Treatment success rate
Analysis of treatment success rate according to species of NTM lung disease patients in Korea
Time frame: Through study completion, at 1 year after treatment start at enrollment
Comparison of the efficacy among different regimens for the treatment of certain species of NTM
Comparison of the outcomes measured by culture conversion among different regimens for the treatment of certain species of NTM
Time frame: Through study completion, at 1 year after treatment start at enrollment
Number of participants with changing culture results during treatment
Number of participants with changing culture results during treatment
Time frame: Through study completion, at 1 year after treatment start at enrollment
Number of participants with treatment-related adverse events
Number of participants with treatment-related adverse events specifically described in the protocol
Time frame: Through study completion, at 1 year after treatment start at enrollment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.